达尔巴万辛治疗骨和关节感染:一个双中心的希腊现实世界的回顾性研究
Christina Petropoulou1, Petros Ioannou2, Georgios Eleftherakis1
1Department of Internal Medicine, University Hospital of Patras, 26504 Patras, Greece.
Pathogens (Basel, Switzerland)
|November 27, 2025
概括
达尔巴万辛为具有挑战性的骨和关节感染提供了一种简化治疗方法,显示出高的疗效和安全性. 这种长效抗生素减少了住院治疗和并发症,在复杂病例中有效.
科学领域:
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
- 整形外科 整形外科 整形外科
背景情况:
- 骨关节感染 (BJIs) 带来了重大的治疗挑战,通常需要长时间的静脉注射 (IV) 抗生素治疗和住院治疗.
- 达尔巴万辛是一种具有扩展活性的脂糖,为简化BJI治疗方案提供了潜在的替代方案.
研究的目的:
- 在现实临床环境中评估达尔巴万辛在治疗各种BJI中的疗效和安全性.
- 评估达尔巴万辛作为单疗法和复杂感染的联合疗法的有效性.
主要方法:
- 在2022-2024年期间,对83名用达尔巴万辛治疗骨质炎,脊髓炎,败血性关节炎或假肢关节感染的患者进行了回顾性分析.
- 收集关于患者人口统计,并发症,感染类型,致病原体,治疗方案和临床结果的数据.
- 记录了90天和180天的不良事件和临床治愈率.
主要成果:
- 这项研究包括83名患者 (平均年龄69岁) 患有多种BJIs,主要是脊椎骨质炎/脊椎椎炎 (48.2%).
- 常见的病原体包括金黄色葡萄球菌 (38.4%) 和肠球菌 (25%). 达尔巴万辛被用作单疗法 (32.4%) 或组合疗法 (67.6%).
- 观察到高临床治愈率:90天后90.4%,180天后92.8%,单疗和组合手臂的疗效相似. 不良事件很少发生 (4.8%).
结论:
- 达尔巴万辛在治疗复杂的骨和关节感染方面表现出高效率和良好的安全性.
- 它的长半衰期简化了治疗,减少了长时间IV接入的需要,并最大限度地减少了住院治疗,使其成为一种有价值的选择,尤其是在门诊亲肠道治疗有限的地方.
相关概念视频
01:28Acute Pyelonephritis II: Diagnostic Studies and Management
291
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
291
01:28Antimicrobial Effectiveness
885
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
885
01:13Bioequivalence studies: Biowaivers
210
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
210
00:57Antibiotic Selection
59.3K
Overview
59.3K
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
224
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
224
01:21Drug Accumulation During Multiple Dosing: Repetitive IV Injections
239
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
239